You're probably right. A company with a successful consumer division, pipelines for cancer drugs, ischaemia drugs, fibrosis drugs, kidney disease drugs, stakes in veterinary medicine, bone disorders, biomarkers, and whatnot - a company like that may be trading at $10 per share and a billion dollar market cap some day in the future and still be considered cheap.
Oh am I only dreaming, or is this burning an eternal flame?
- Forums
- ASX - By Stock
- AN1
- Evolis display at Soul Pattinson Pitt St Sydney
Evolis display at Soul Pattinson Pitt St Sydney, page-16
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $350 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 5022 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.006 |
1 | 300000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
2 | 500000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 5022 | 1 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
Last trade - 11.14am 09/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |